Hemolytic-uremic Syndrome synonyms

Hemolytic-uremic syndrome (HUS) is primarily referred to by its standard name, though it is occasionally historically documented as Gasser syndrome. While the condition is clinically categorized into typical (STEC-HUS) and atypical (aHUS) forms, these terms serve as the standard medical nomenclature used by clinicians and researchers worldwide to distinguish between infectious and genetic causes.

What are the common names and synonyms for Hemolytic-uremic Syndrome?

In medical literature, Hemolytic-uremic syndrome is the universally accepted term. Historically, you may encounter the name "Gasser syndrome," named after Conrad Gasser, who first described the condition in 1955. While this historical term appears in older medical textbooks, it is rarely used in contemporary clinical practice. In international classification systems, the disease is formally coded under the umbrella of thrombotic microangiopathies. Researchers and physicians now prefer to classify Hemolytic-uremic syndrome based on its underlying trigger, leading to the common usage of the abbreviations STEC-HUS (Shiga toxin-producing E. coli HUS) and aHUS (atypical Hemolytic-uremic syndrome).

Why are there different names for this condition?

The nomenclature for Hemolytic-uremic syndrome has evolved significantly as our understanding of its pathophysiology has deepened. Historically, the condition was viewed as a singular entity. However, medical researchers eventually identified that cases caused by bacterial infections (typically E. coli) behaved differently than those caused by genetic mutations in the complement system. This led to the formal distinction between "typical" and "atypical" forms. Consequently, the naming conventions shifted to reflect these distinct biological pathways, helping physicians tailor treatments—such as antibiotics for STEC-HUS versus complement-inhibitor therapies for aHUS—more effectively.

How is Hemolytic-uremic Syndrome classified in medical databases?

To ensure consistency in medical records and research, Hemolytic-uremic syndrome is indexed in major global databases using specific codes. These identifiers are essential for patients navigating their diagnostic journey:

• Orphanet: Classified as ORPHA455 (aHUS) and ORPHA854 (STEC-HUS).


• ICD-10: Recognized under code D59.3 (Hemolytic-uremic syndrome).


• OMIM: Atypical Hemolytic-uremic syndrome is indexed under various entries (e.g., #235400) depending on the specific genetic mutation involved.


• NIH GARD: Lists the condition under the standard name Hemolytic-uremic syndrome to provide centralized, reliable information.

Which name should patients and caregivers use?

When speaking with healthcare providers or searching for resources on DiseaseMaps.org, where 93 members have shared their experiences, it is best to use the full term Hemolytic-uremic syndrome. If your diagnosis involves a specific trigger, using the terms "atypical HUS" or "STEC-HUS" will help you find the most relevant clinical trials and patient support communities. Using these specific terms ensures that you are accessing information tailored to the underlying mechanism of your specific case, which is critical for understanding prognosis and treatment options.

Next steps

• Consult with a nephrologist or hematologist to confirm the specific classification of your condition.


• Request a copy of your genetic testing report if you have been diagnosed with atypical Hemolytic-uremic syndrome.


• Join the DiseaseMaps.org community to connect with others who have navigated similar diagnostic paths.


• Visit the NIH GARD website to access the latest clinical literature and research updates.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the guidance of your physician or qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): rarediseases.info.nih.gov


• Orphanet (The portal for rare diseases and orphan drugs): orpha.net


• Online Mendelian Inheritance in Man (OMIM): omim.org